These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25632994)

  • 1. A comparison between National Healthcare Safety Network laboratory-identified event reporting versus traditional surveillance for Clostridium difficile infection.
    Durkin MJ; Baker AW; Dicks KV; Lewis SS; Chen LF; Anderson DJ; Sexton DJ; Moehring RW
    Infect Control Hosp Epidemiol; 2015 Feb; 36(2):125-31. PubMed ID: 25632994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 2 Clostridium difficile surveillance methods: National Healthcare Safety Network's laboratory-identified event reporting module versus clinical infection surveillance.
    Gase KA; Haley VB; Xiong K; Van Antwerpen C; Stricof RL
    Infect Control Hosp Epidemiol; 2013 Mar; 34(3):284-90. PubMed ID: 23388363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overreporting healthcare-associated C. difficile: A comparison of NHSN LabID with clinical surveillance definitions in the era of molecular testing.
    Albert K; Ross B; Calfee DP; Simon MS
    Am J Infect Control; 2018 Sep; 46(9):998-1002. PubMed ID: 29655671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions.
    Lambert PJ; Dyck M; Thompson LH; Hammond GW
    Infect Control Hosp Epidemiol; 2009 Oct; 30(10):945-51. PubMed ID: 19732008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance and epidemiology of Clostridioides difficile infection using the national health surveillance network criteria: A 7-year study from Mumbai, India.
    Rohra S; Poojary A; Patil P; John S; Michael R; Johnson S; Pardeshi P
    Indian J Med Microbiol; 2023; 46():100425. PubMed ID: 37945118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of Clostridium difficile infection surveillance systems in Europe, 2011.
    Kola A; Wiuff C; Akerlund T; van Benthem BH; Coignard B; Lyytikäinen O; Weitzel-Kage D; Suetens C; Wilcox MH; Kuijper EJ; Gastmeier P;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27469420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals.
    Zilberberg MD; Tabak YP; Sievert DM; Derby KG; Johannes RS; Sun X; McDonald LC
    Infect Control Hosp Epidemiol; 2011 Jul; 32(7):649-55. PubMed ID: 21666394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying sources of bias in National Healthcare Safety Network laboratory-identified Clostridium difficile infection rates.
    Haley VB; DiRienzo AG; Lutterloh EC; Stricof RL
    Infect Control Hosp Epidemiol; 2014 Jan; 35(1):1-7. PubMed ID: 24334790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile infections in Veterans Health Administration acute care facilities.
    Evans ME; Simbartl LA; Kralovic SM; Jain R; Roselle GA
    Infect Control Hosp Epidemiol; 2014 Aug; 35(8):1037-42. PubMed ID: 25026621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile infection in Ohio hospitals and nursing homes during 2006.
    Campbell RJ; Giljahn L; Machesky K; Cibulskas-White K; Lane LM; Porter K; Paulson JO; Smith FW; McDonald LC
    Infect Control Hosp Epidemiol; 2009 Jun; 30(6):526-33. PubMed ID: 19419272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease?
    Dubberke ER; McMullen KM; Mayfield JL; Reske KA; Georgantopoulos P; Warren DK; Fraser VJ
    Infect Control Hosp Epidemiol; 2009 Apr; 30(4):332-7. PubMed ID: 19239377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection.
    Dubberke ER; Butler AM; Hota B; Khan YM; Mangino JE; Mayer J; Popovich KJ; Stevenson KB; Yokoe DS; McDonald LC; Jernigan J; Fraser VJ;
    Infect Control Hosp Epidemiol; 2009 Jun; 30(6):518-25. PubMed ID: 19419269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter study of Clostridium difficile infection rates from 2000 to 2006.
    Dubberke ER; Butler AM; Yokoe DS; Mayer J; Hota B; Mangino JE; Khan YM; Popovich KJ; Fraser VJ
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1030-7. PubMed ID: 20695799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005.
    Kutty PK; Benoit SR; Woods CW; Sena AC; Naggie S; Frederick J; Engemann J; Evans S; Pien BC; Banerjee SN; Engel J; McDonald LC
    Infect Control Hosp Epidemiol; 2008 Mar; 29(3):197-202. PubMed ID: 18241032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection.
    Abbett SK; Yokoe DS; Lipsitz SR; Bader AM; Berry WR; Tamplin EM; Gawande AA
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1062-9. PubMed ID: 19751156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated surveillance of Clostridium difficile infections using BioSense.
    Benoit SR; McDonald LC; English R; Tokars JI
    Infect Control Hosp Epidemiol; 2011 Jan; 32(1):26-33. PubMed ID: 21128815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007.
    Weiss K; Boisvert A; Chagnon M; Duchesne C; Habash S; Lepage Y; Letourneau J; Raty J; Savoie M
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):156-62. PubMed ID: 19125681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance for Clostridium difficile infection in nursing homes.
    Mylotte JM; Russell S; Sackett B; Vallone M; Antalek M
    J Am Geriatr Soc; 2013 Jan; 61(1):122-5. PubMed ID: 23253029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile surveillance: a multicenter comparison of LabID events and use of standard definitions.
    Baier R; Morphis B; Marsella M; Mermel LA
    Infect Control Hosp Epidemiol; 2013 Jun; 34(6):653-5. PubMed ID: 23651906
    [No Abstract]   [Full Text] [Related]  

  • 20. How to: Surveillance of Clostridium difficile infections.
    Krutova M; Kinross P; Barbut F; Hajdu A; Wilcox MH; Kuijper EJ;
    Clin Microbiol Infect; 2018 May; 24(5):469-475. PubMed ID: 29274463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.